A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report

Vaccine (2022) - Comments
doi: 10.1016/j.vaccine.2022.02.030 pubmed: 35177302 issn: 0264-410x issn: 1873-2518

Taisei Masuda, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron Philip Schuring, Mitsuhiro Mori